Funding for this research was provided by:
Bill and Melinda Gates Foundation (#OPP1210792)
Received: 11 June 2021
Accepted: 4 March 2022
First Online: 5 April 2022
: UK Health Research Authority and REC approval was granted by the London – Westminster Research Ethics Committee on the 12th December 2019 (REC reference 19/LO/1669).
: Not applicable.
: MJL has received grants and honoraria from Gilead Sciences and Viiv Healthcare not related to this work. Rockefeller University has a patent on 3BNC117 and 10-1074 on which MCN is an inventor. The patent has been licenced to Gilead. All other authors declare that they have no competing interests.